Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview

10592studies shown

Showing 7,405-7,416 of 10,592

Drug study icon

CompletedNCT00573248

Nicotine and Behavior in Adult ADHD

This summary needs review. Please check the official study record and contact the research team for details.

In United States

ADHDDrugFrom 18 Years to 45 Years

Countries: United States
Sponsor: University of California, Irvine
Condition: ADHD

Other study type icon

CompletedNCT00135772

Nicotine and Cotinine Levels in Smokers With Schizophrenia and Schizoaffective Disorder - 2

This summary needs review. Please check the official study record and contact the research team for details.

In United States

Schizophrenia, AddictionOtherFrom 18 Years to 70 Years

Countries: United States
Sponsor: National Institute on Drug Abuse (NIDA)
Condition: Schizophrenia, Addiction

Behavioral study icon

CompletedNCT01213524

Nicotine and Sensorimotor Replacement for Smoking in Smokers With Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In United States

Schizophrenia, AddictionBehavioralFrom 18 Years to 99 Years

Countries: United States
Sponsor: Brown University
Condition: Schizophrenia, Addiction

Drug study icon

CompletedNCT03580525

Nicotine Delivery Rate and Its Abuse Potential: Impact of Menthol

This summary needs review. Please check the official study record and contact the research team for details.

In United States

AddictionDrugFrom 18 Years to 35 Years

Countries: United States
Sponsor: Yale University
Condition: Addiction

Drug study icon

CompletedNCT05159934

Nicotine Differences in Smokers

This summary needs review. Please check the official study record and contact the research team for details.

In United States

AddictionDrugFrom 21 Years to 65 Years

Countries: United States
Sponsor: Yale University
Condition: Addiction

Behavioral study icon

CompletedNCT00218283

Nicotine Lozenge to Reduce Smokeless Tobacco Use

This summary needs review. Please check the official study record and contact the research team for details.

In United States

AddictionBehavioralFrom 18 Years to 70 Years

Countries: United States
Sponsor: National Institute on Drug Abuse (NIDA)
Condition: Addiction

Drug study icon

CompletedNCT00392379

Nicotine Lozenges for Treatment of Smokeless Tobacco Addiction

This summary needs review. Please check the official study record and contact the research team for details.

In United States

AddictionDrugOver 18 Years

Countries: United States
Sponsor: Mayo Clinic
Condition: Addiction

Drug study icon

TerminatedNCT00046813

Nicotine Patch for Addiction in Individuals With Schizophrenia or Schizoaffective Disorder - 1

This summary needs review. Please check the official study record and contact the research team for details.

In United States

Addiction, SchizophreniaDrugFrom 18 Years to 70 Years

Countries: United States
Sponsor: National Institute on Drug Abuse (NIDA)
Condition: Addiction, Schizophrenia

Drug study icon

CompletedNCT00625131

Nicotine Patch Pretreatment for Smoking Cessation in PTSD

This summary needs review. Please check the official study record and contact the research team for details.

In United States

PTSD, AddictionDrugFrom 18 Years to 70 Years

Countries: United States
Sponsor: US Department of Veterans Affairs
Condition: PTSD, Addiction

Drug study icon

CompletedNCT02792426

Nicotine Pharmacokinetics From Research Electronic Nicotine Delivery System S-TA-U001 in Smokers and E-Cigarette Users

This summary needs review. Please check the official study record and contact the research team for details.

In United States

AddictionDrugFrom 21 Years to 65 Years

Countries: United States
Sponsor: NJOY, Inc.
Condition: Addiction

Drug study icon

CompletedNCT02676375

Nicotine Receptor Density & Response to Nicotine Patch: Pt 2 Extended Treatment

This summary needs review. Please check the official study record and contact the research team for details.

In United States

SchizophreniaDrugOver 21 Years

Countries: United States
Sponsor: Brentwood Biomedical Research Institute
Condition: Schizophrenia

Other study type icon

CompletedNCT01788943

Nicotine Receptor Levels and Smoking Cessation

This summary needs review. Please check the official study record and contact the research team for details.

In United States

AddictionOtherFrom 18 Years to 65 Years

Countries: United States
Sponsor: University of Pennsylvania
Condition: Addiction

Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.